Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Sinovac Quadrivalent Influenza Vaccine vs VaxigripTetra in Chile
NCT05494047Phase 3Unknown
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Jul 2022
- Primary completion
- May 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of TetrAnflu in influenza, sponsored by Pontificia Universidad Católica de Chile. Status: unknown.
02
Drugs
TetrAnflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05494047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494047.